Gun violence incidents have been happening more frequently than ever to the point that some don’t even make headlines anymore. Since the Sandy Hook shooting there have been at least 2,108 mass shootings. When will someone finally step up and do something to end mass shootings? The answer isn’t politicians as Americans have the right to bear arms of course. If not our politicians, then what, then who?
The answer is small public companies. These companies are coming out with weapon detection technology which will potentially stop mass shootings in public spaces so people can stop being afraid to go to their own school, movie theatre, night club, sporting event, a transportation hub. Decades ago some would say fearing to go to your own school is irrational but unfortunately who could ever foresee the future that we are now living in.
I am not talking about the metal detectors or body scanners at the airports which are completely non-effective. There is an immediate demand for the revolution in weapons detection technologies that we can thank the small, public companies for. Without being extremely tedious and stopping each and every person to check for weapons this technology works from behind the scenes and combines newly immerged technology into innovative solutions to stop mass shootings by scanning crowds completely in order to identify hidden weapons on someone or in a backpack/bag.
Investing in AI
Solutions to stop mass shootings are slowly beginning to unravel into the daily lives of the public. In part, we can thank artificial intelligence, machine learning and deep learning. Artificial intelligence could be defined as being able to consolidate human like intelligence into machines or computers. The two sub levels of artificial intelligence are machine learning and deep learning.
Machine learning allows for a machine to complete tasks based on an algorithm written by humans. Machines learn by themselves in order to provide date and make accurate predictions.
On the other hand, deep learning is the solution to end one of America’s biggest problems. Deep learning identifies patterns and classifies these patterns into numerous levels of information.
When thinking about how deep learning can potentially end mass shootings think about wave and radar imaging. It has been around for decades. Walking into a store and the door automatically opens because it detects you walking in is an example as well as police scanners in order for you not to be pulled over.
Thinking as small as the everyday radar technology can allow for you to see the bigger picture and technology now is pushing what these radar waves can potentially do. Advanced systems are allowing for Nanosensors to detect signals that are highly sensitive and operate similarly to biological processes.
Top 3 Weapons Detection Stocks To Watch
The companies that are standing out today are those that are applying artificial intelligence into their technology. These 3 emerging companies are looking to become the first to end mass shootings.
Liberty Defense Holdings, Ltd. (TSX.V: SCAN)
Liberty Defense (SCAN.V) has developed a product known as HEXWAVE. Using 3D image technology and ML to scan crows, security checkpoints are no longer needed and can detect threats before they are carried out. Designed for indoor and outdoor use, this product can detect metallic and non-metallic threat items.
The company just went public and is still in its testing and development stage. Liberty Defense (SCAN.V) has secured a license from MIT in addition to a technology transfer agreement for patents related to 3D radar technology. We have yet to see if this technology can work in real life situations but it does have much promise for the future.
What Sets Liberty Defense
(SCAN.V) HEXWAVE Apart From The Competition?
HEXWAVE is the first practical application of real-time, next-gen 3D imaging. It uses low power radar energy which helps generate real-time 3D images to detect threat options such as guns, knives, explosives, and other threats through clothing and baggage. This product creates high fidelity, real-time concealed threat images which are assessed using deep learning and AI. Thus alerting security regarding the decision response hierarchy.
HEXWAVE – A Product Integrating A New Wave of Technology
- Detects metallic and non-metallic threat objects
- Designed for indoor/outdoor use
- Covert and overt panel options
- Real-time accurate detection
- AI/deep learning enhances sensor fidelity and decision hierarchy
- Panels can be scaled to provide a deep-layered approach
- Can be used stand-alone or combined with other security measures
HEXWAVE provides enhanced security options without disrupting the flow of daily life by scanning quickly and unobtrusively. Ideal for use in high traffic areas and a huge leap from the traditional metal detector.
The demand is present and Liberty Defense (SCAN.V) has already inked two Memorandums of Understanding for beta testing of HEXWAVE, which is expected to commence this year! With Canada’s Rogers Arena, Vancouver’s large-scale venues and Sleiman Enterprises, one of Florida’s largest real estate companies developing and managing malls, hotels, and shopping centers, Liberty Defense (SCAN.V) has created a strong pipeline of premier customers.
Patriot One Technologies (TSX.V: PAT) (OTCQX: PTOTF)
The first company is Patriot One which has seen profit gains over the past year. Patriot One has developed a three-prong weapons detection system. The first piece of Patriot One is their PATSCAN CMR. Like the radar technology discussed earlier, you can place this technology at certain points in order to identify radio/radar wave emissions in order to fully target concealed weapons.
PATSCAN VRS is Patriot One’s AI and existing camera infrastructure can scan and alert security of any potential threats.
The latest addition to Patriot One is PATSCAN STS. This technology is able to detect and scan potential lethal airborne chemicals and explosives with parts per billion sensitivities. This technology is in tune with the AI system in order to scan and alert possible threats. Patriot One is a major favorite of investors as the company continues to advance.
Plymouth Rock Technologies Inc. (OTC: AXDRF) (CSE: PRT)
The next company is Plymouth Rock who has developed MIRIAD (Millimeter Remote Imaging from Airborne Drone) a compact radio frequency sensor designed specifically for drones to detect weapons in an outdoor environment.
MIRIAD works by using an ultra-lightweight antenna to capture radar images. The radar images along with HD video uses AI and AR (augmented reality) to indicate any possible concealed threat and its exact location on subjects.
Plymouth has also come out with Wi-Ti (Wireless Threat Indication) which analyzes Wi-Fi signals that can be altered when they come into contact with concealed threat items. Wi-Ti can detect threat and non-threat items over an area with Wi-Fi.
An even smaller issue Plymouth has solved for the public is a compact radar system for imaging through shoes to detect concealed items. In return, you may no longer need to take off your shoes in airports.
Plymouth is a big investment as there is a huge military and security and search and rescue market for drones. Plymouth is definitely a company for investors to watch.
Looking Into The Future
We live in a world where threats to our safety, both large and small, have impacted the way we as a society live. Increased security measures are being taken in several aspects of daily life such as entering a school or even a baseball game, often causing large delays. Worse off, not all current security measures are stopping these threats before they happen.
With government spending on the rise and global threats increasing, defense and weapons detection stocks hit the radar of many investors. Is now the time to have them on your watchlist as well?
Acadia (ACAD) Stock Price is up 60% This Month; Bullish Signal For Biotechs?
One sector that has always been a favorite of investors of all varieties is the pharmaceutical sector and all investors like a turnaround story. Over the years, ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) had been one of the better-known strugglers in the industry. That was reflected in the stock price as well. But recent developments have breathed new life in the stock, which could be an indicator for the biotech industry at large.
Biotech Stocks To Watch: PharmaCyte Biotech (PMCB)
There has been no lack of attention on biotech penny stocks this year. At the beginning of August, one small biotech stock broke to highs of over $10 from a starting price below $2 a share after releasing news. PharmaCyte Biotech (PMCB) focuses on ways to effectively deliver treatments to patients with diseases ranging from cancer to diabetes.
The company’s proprietary cellulose-based live-cell encapsulation technology known as “Cell-in-a-Box®is the platform that the company uses to develop its therapy delivery methods. For most of the quarter, shares of PMCB stock have traded between $0.033 and $0.04 with volume recently surging.
On September 12, PharmaCyte saw more than 4 million shares trade; well above its daily average. Most of the attention surrounding the company has been on two things. First, its progress with Cell-In-A-Box and the application for Pancreatic cancer has continued to progress. The company brought on Dr. Manuel Hidalgo, has confirmed that he will be Principal Investigator (PI) for PharmaCyte’s planned clinical trial in locally advanced, inoperable pancreatic cancer (LAPC) now that he is at Weill Cornell Medical Center.
Second, the company has been ramping up for a much-anticipated shareholder update call on September 20. The call will cover PharmaCyte’s preparations for submission of its Investigational New Drug application (IND) to the U.S. Food and Drug Administration (FDA) to treat locally advanced, inoperable pancreatic cancer and developments related to PharmaCyte’s product pipeline on which PharmaCyte has been working and that have not yet been reported in a press release.
Acadia (ACAD) Stock Price: Important Developments
People who had held on to the stock through the barren years got a nice boost recently. This came after Acadia’s well-known medicine Nuplazid recorded better than expected sales. In addition to that, there were encouraging results from a dementia-driven psychosis study. Hence, it is important to figure out whether it is perhaps time to buy the stock.
While the signs are no doubt encouraging, it is important to note that data reveals that around 60,000 people in the United States are diagnosed with Parkinson’s every year. Out of those, a large proportion (50% to 80%) suffers from dementia. Hence it can be argued that the market is simply not too big for Acadia’s Nuplazid.
Moreover, different types of dementia are brought on by Alzheimer’s disease, which is why all of it might not actually fall into Acadia’s lap. That being said, it is also well known that antipsychotic drugs have only been approved for the treatment of Parkinson’s and hence the Alzheimer’s market is already out of the question.
Projections suggest that the sale of Nuplazid could grow to more than $1 billion in 2023 from $224 million in 2018. While that is encouraging, it is also important to note that the growth has been priced into the Acadia stock price.
However, if Acadia’s plans for growth somehow run into any trouble, then there is every chance of the stock price plummeting once again. The company is recovering and there is some time before the patient population for Nuplazid can be expanded sufficiently. In the meantime, investors need to be a bit more patient.
Shares of ACAD are up over 60% over the past week and made a new multi-year high of $43.98.
Advanced Micro Devices (AMD) Stock Price Consolidates After the Recent Rally: What Next?
It sometimes so happens that the price action and activity around a stock reaches a decisive stage, from which it can go only one way or another. In other words, it is the moment when the future of a stock is a straight shootout between the bulls and the bears.
The Advanced Micro Devices, Inc. (NASDAQ:AMD) stock has now reached such a stage according to keen observers and hence the stock is now trading within a very narrow range as the squeeze continues. In such a situation, it is only natural for investors to wonder which way this whole thing is going to go in the short term.
First and foremost, it is important to point out that since Lisa Su took over as the Chief Executive Officer in 2014, AMD has managed to stage a remarkable turnaround. Although the process has been slow, it proved to be highly lucrative for those investors who were patient. The stock has risen steadily over the past three years and rallied from $2 to around $30.
However, at the time, the investors had backed the company’s turnaround but now the story has changed and the turnaround has concluded. The bulls seem to think that the run is going to continue while bears believe that with the conclusion of the turnaround, the stock is all set to fall.
After all, if there is no further upside, then there is no point in holding the stock. This has caused uncertainty in the stock and its price action. Analysts believe that while the turnaround story had resulted in enormous gains for many investors, the stock is now expected to mirror the performance of the broader market. This factor lays credence to the bears’ position and moreover, the small matter of a looming Presidential election needs to be considered as well. Markets are generally flat in the lead-up and hence, analysts believe that although AMD might continue to be range-bound, it is unlikely that it is going to go on a rally.
Stock Price Newsletter – September 18, 2019
4 Penny Stocks Catching Attention This Week
Several economic and sector events have sparked interest in a number of small-cap and micro-cap stocks this week.
Airline Stocks In Focus; Spur Interest In Detection Tech Companies?
The latest mix of attacks and focus on airlines could have a different impact on sectors like weapons detection & defense. What could this mean for stocks to watch this week?
Top Biotech Stocks To Watch This Week
The values of biotech equities, however, do generally start to pick up as the year winds down. The underlying reason is that the latter part of the year is chock-full of key data readouts, regulatory decisions, and thousands of scientific conferences across the globe.
Join Our Newsletter
Get stock alerts, news & trending stock alerts straight to your inbox!
We keep all user information pricate & promise to never spam.*
Search Stock Price (StockPrice.com)
Biotechnology1 week ago
This Biotech Stock Could Hold the Key to a Multi-Billion Dollar Market Shake-up
Biotechnology2 weeks ago
Tiziana Life Sciences (TLSA) Reports Positive Phase 2a Clinical Data Exhibiting Positive Clinical Activity with Milciclib Monotherapy in Advanced Sorafenib-refractory or -intolerant Patients with Unresectable or Metastatic Hepatocellular Carcinoma
Biotechnology1 week ago
Multi-Billion Dollar Markets Are Ready For A Shake-Up; 1 Biotech Stock Could Hold The Key
Featured3 days ago
Tiziana Life Sciences (TLSA) Announces FDA Approval to Initiate Phase I Clinical Trial with Orally Administered Foralumab in Healthy Volunteers
Featured1 week ago
This Biotech Stock is Looking to Deliver Huge Positive Change
Featured3 days ago
Top 4 Penny Stocks To Watch This Week
Biotechnology1 week ago
Are Biotech Stocks Setting The Stage For Another Bull Trend?
Biotechnology1 week ago
Tiziana Reports Phase 1 Clinical Data Demonstrating Nasal Treatment with Foralumab was Well-tolerated and Produced Positive Trend in Biomarkers of Immunomodulation and Anti-inflammation in Healthy Volunteers